Drug Name: Omvoh
Active Ingredient: mirikizumab-mrkz
Indication: To treat ulcerative colitis
Approval Date: 10/26/2023
Company: Eli Lilly and Company
More: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761279s000lbl.pdf
Drug Name: Omvoh
Active Ingredient: mirikizumab-mrkz
Indication: To treat ulcerative colitis
Approval Date: 10/26/2023
Company: Eli Lilly and Company
More: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761279s000lbl.pdf